Literature DB >> 30361415

DUSP22-rearranged anaplastic lymphomas are characterized by specific morphological features and a lack of cytotoxic and JAK/STAT surrogate markers.

Arantza Onaindia1, Sonia González de Villambrosía2, Lucía Prieto-Torres3, Socorro M Rodríguez-Pinilla3, Santiago Montes-Moreno4, Carmen González-Vela4, Miguel A Piris4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30361415      PMCID： PMC6442961          DOI： 10.3324/haematol.2018.205880

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  9 in total

1.  Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements.

Authors:  Rebecca L King; Linda N Dao; Ellen D McPhail; Elaine S Jaffe; Jonathan Said; Steven H Swerdlow; Christopher A Sattler; Rhett P Ketterling; Jagmohan S Sidhu; Eric D Hsi; Shridevi Karikehalli; Liuyan Jiang; Sarah E Gibson; Sarah L Ondrejka; Alina Nicolae; William R Macon; Surendra Dasari; Edgardo Parrilla Castellar; Andrew L Feldman
Journal:  Am J Surg Pathol       Date:  2016-01       Impact factor: 6.394

2.  Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing.

Authors:  Andrew L Feldman; Ahmet Dogan; David I Smith; Mark E Law; Stephen M Ansell; Sarah H Johnson; Julie C Porcher; Nazan Ozsan; Eric D Wieben; Bruce W Eckloff; George Vasmatzis
Journal:  Blood       Date:  2010-10-28       Impact factor: 22.113

3.  DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study.

Authors:  Martin Bjerregård Pedersen; Stephen Jacques Hamilton-Dutoit; Knud Bendix; Rhett P Ketterling; Patrick P Bedroske; Ivy M Luoma; Christopher A Sattler; Rebecca L Boddicker; N Nora Bennani; Peter Nørgaard; Michael Boe Møller; Torben Steiniche; Francesco d'Amore; Andrew L Feldman
Journal:  Blood       Date:  2017-05-18       Impact factor: 22.113

4.  Primary cutaneous anaplastic large cell lymphomas with 6p25.3 rearrangement exhibit particular histological features.

Authors:  Arantza Onaindia; Santiago Montes-Moreno; Socorro M Rodríguez-Pinilla; Ana Batlle; Sonia González de Villambrosía; Antonio M Rodríguez; Víctor Alegre; Glenda M Bermúdez; Carmen González-Vela; Miguel A Piris
Journal:  Histopathology       Date:  2015-02-04       Impact factor: 5.087

Review 5.  FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue.

Authors:  Roland A Ventura; Jose I Martin-Subero; Margaret Jones; Joanna McParland; Stefan Gesk; David Y Mason; Reiner Siebert
Journal:  J Mol Diagn       Date:  2006-05       Impact factor: 5.568

6.  Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target.

Authors:  Roberto Chiarle; William J Simmons; Honjying Cai; Girish Dhall; Alberto Zamo; Regina Raz; James G Karras; David E Levy; Giorgio Inghirami
Journal:  Nat Med       Date:  2005-05-15       Impact factor: 53.440

7.  ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes.

Authors:  Edgardo R Parrilla Castellar; Elaine S Jaffe; Jonathan W Said; Steven H Swerdlow; Rhett P Ketterling; Ryan A Knudson; Jagmohan S Sidhu; Eric D Hsi; Shridevi Karikehalli; Liuyan Jiang; George Vasmatzis; Sarah E Gibson; Sarah Ondrejka; Alina Nicolae; Karen L Grogg; Cristine Allmer; Kay M Ristow; Wyndham H Wilson; William R Macon; Mark E Law; James R Cerhan; Thomas M Habermann; Stephen M Ansell; Ahmet Dogan; Matthew J Maurer; Andrew L Feldman
Journal:  Blood       Date:  2014-06-03       Impact factor: 22.113

8.  Chromosomal rearrangements of 6p25.3 define a new subtype of lymphomatoid papulosis.

Authors:  Laszlo J Karai; Marshall E Kadin; Eric D Hsi; Jason C Sluzevich; Rhett P Ketterling; Ryan A Knudson; Andrew L Feldman
Journal:  Am J Surg Pathol       Date:  2013-08       Impact factor: 6.394

9.  Standardisation of EGFR FISH in colorectal cancer: results of an international interlaboratory reproducibility ring study.

Authors:  Andrea Sartore-Bianchi; Steffen Fieuws; Silvio Veronese; Mauro Moroni; Nicola Personeni; Milo Frattini; Valter Torri; Federico Cappuzzo; Sara Vander Borght; Vittoria Martin; Margaret Skokan; Armando Santoro; Marcello Gambacorta; Sabine Tejpar; Marileila Varella-Garcia; Salvatore Siena
Journal:  J Clin Pathol       Date:  2011-11-30       Impact factor: 3.411
  9 in total
  5 in total

1.  Circulating JNK pathway-associated phosphatase level correlates with decreased risk, activity, inflammation level and reduced clinical response to tumor necrosis factor-α inhibitor in Crohn disease patients.

Authors:  Xue Shi; Wei Yang; Nian Wang; Junyi Zhu
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

2.  Molecular profiling of Chinese systemic anaplastic large cell lymphoma patients: novel evidence of genetic heterogeneity.

Authors:  Li-Hua Zhong; Zhi-Da Wu; Jian-Chao Wang; Zai-Zeng Wu; Fang-Fang Chen; Wei-Feng Zhu; Yan-Ping Chen; Gang Chen
Journal:  Ann Transl Med       Date:  2021-01

Review 3.  PD-1/PD-L1 Pathway: A Therapeutic Target in CD30+ Large Cell Lymphomas.

Authors:  Wei Xie; L Jeffrey Medeiros; Shaoying Li; Guilin Tang; Guang Fan; Jie Xu
Journal:  Biomedicines       Date:  2022-07-04

4.  Combined Modality Management of Sinonasal Anaplastic Lymphoma Kinase Negative Anaplastic Large Cell Lymphoma in a Geriatric Patient-Report of a Rare Case.

Authors:  Ahitagni Biswas; Sorun Shishak; Swarnaditya Roy; Aanchal Kakkar
Journal:  Head Neck Pathol       Date:  2021-01-04

5.  Freiburg Neuropathology Case Conference : Back Pain and Rapidly Progressing Gait Disorder in a 70-year-old Patient.

Authors:  D Erny; U Taschner; J Nakagawa; H Urbach; M Prinz; C A Taschner
Journal:  Clin Neuroradiol       Date:  2020-09       Impact factor: 3.649
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.